While mitochondrial dysfunction in the CNS of MS patients is now well established (see Section 2), recent research has also found metabolic and mitochondrial alterations in peripheral blood mononuclear cells (PBMCs) of MS patients, especially in CD4+ T cells and in T cells derived from the spleen and CNS of EAE mice. Here, CD4 is linked to myeloid sarcoma.